Guardant Health Stock Analysis
GH Stock | USD 17.59 1.52 9.46% |
Guardant Health is undervalued with Real Value of 25.85 and Target Price of 53.0. The main objective of Guardant Health stock analysis is to determine its intrinsic value, which is an estimate of what Guardant Health is worth, separate from its market price. There are two main types of Guardant Health's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Guardant Health's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Guardant Health's stock to identify patterns and trends that may indicate its future price movements.
The Guardant Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Guardant Health is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Guardant Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Guardant Health's ongoing operational relationships across important fundamental and technical indicators.
Guardant |
Guardant Stock Analysis Notes
About 94.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.28. Guardant Health had not issued any dividends in recent years. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1373 people. To learn more about Guardant Health call Helmy Eltoukhy at 855 698 8887 or check out https://guardanthealth.com.Guardant Health Quarterly Total Revenue |
|
Guardant Health Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Guardant Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Guardant Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Guardant Health generated a negative expected return over the last 90 days | |
Guardant Health has high historical volatility and very poor performance | |
Guardant Health has high likelihood to experience some financial distress in the next 2 years | |
The company generated the yearly revenue of 563.95 M. Annual Net Loss to common stockholders was (479.45 M) with gross profit of 293.21 M. | |
Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35. | |
Guardant Health has a poor financial position based on the latest SEC disclosures | |
Over 94.0% of the company shares are owned by institutional investors | |
Latest headline from investing.com: FDA to review Guardant Healths cancer screening test |
Guardant Health Upcoming and Recent Events
Earnings reports are used by Guardant Health to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Guardant Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
22nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Guardant Largest EPS Surprises
Earnings surprises can significantly impact Guardant Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2020-02-24 | 2019-12-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2019-03-12 | 2018-12-31 | -0.35 | -0.3 | 0.05 | 14 | ||
2019-05-09 | 2019-03-31 | -0.37 | -0.3 | 0.07 | 18 |
Guardant Health Thematic Classifications
In addition to having Guardant Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Guardant Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Guardant Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Guardant Health backward and forwards among themselves. Guardant Health's institutional investor refers to the entity that pools money to purchase Guardant Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Geode Capital Management, Llc | 2023-12-31 | 2.5 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.5 M | Capital Research Global Investors | 2023-12-31 | 2.3 M | Fidelity International Ltd | 2023-12-31 | 2 M | T. Rowe Price Associates, Inc. | 2023-12-31 | 1.8 M | Goldman Sachs Group Inc | 2023-12-31 | 1.8 M | Credit Suisse First Boston (csfb) | 2023-12-31 | 1.8 M | Clearbridge Advisors, Llc | 2023-12-31 | 1.5 M | Franklin Resources Inc | 2023-12-31 | 1.4 M | Vanguard Group Inc | 2023-12-31 | 11.1 M | Blackrock Inc | 2023-12-31 | 10.8 M |
Guardant Market Capitalization
The company currently falls under 'Mid-Cap' category with a market capitalization of 2.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guardant Health's market, we take the total number of its shares issued and multiply it by Guardant Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Guardant Profitablity
Guardant Health's profitability indicators refer to fundamental financial ratios that showcase Guardant Health's ability to generate income relative to its revenue or operating costs. If, let's say, Guardant Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Guardant Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Guardant Health's profitability requires more research than a typical breakdown of Guardant Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin (PM) of (0.85) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.73) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.73. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.27) | (0.28) | |
Return On Capital Employed | (0.36) | (0.37) | |
Return On Assets | (0.27) | (0.28) | |
Return On Equity | (3.02) | (3.17) |
Management Efficiency
Guardant Health has Return on Asset (ROA) of (0.1764) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1764. This is way below average. Likewise, it shows a return on total equity (ROE) of (4.3813) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.28. The current Return On Capital Employed is estimated to decrease to -0.37. As of now, Guardant Health's Debt To Assets are increasing as compared to previous years. The Guardant Health's current Fixed Asset Turnover is estimated to increase to 2.51, while Total Assets are projected to decrease to under 1.4 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.42 | 1.35 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 1.31 | 1.24 | |
Enterprise Value Over EBITDA | (6.25) | (6.57) | |
Price Book Value Ratio | 19.09 | 13.78 | |
Enterprise Value Multiple | (6.25) | (6.57) | |
Price Fair Value | 19.09 | 13.78 | |
Enterprise Value | 0.00 | 0.00 |
The analysis of Guardant Health's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Guardant Health's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Guardant Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.898 |
Technical Drivers
As of the 23rd of April, Guardant Health retains the market risk adjusted performance of (0.15), and Risk Adjusted Performance of (0.05). Guardant Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have analyze and collected data for thirteen technical drivers for Guardant Health, which can be compared to its competitors. Please check out Guardant Health information ratio, and the relationship between the coefficient of variation and value at risk to decide if Guardant Health is priced fairly, providing market reflects its last-minute price of 17.59 per share. Given that Guardant Health has information ratio of (0.11), we strongly advise you to confirm Guardant Health's regular market performance to make sure the company can sustain itself at a future point.Guardant Health Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Guardant Health middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Guardant Health. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Guardant Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Guardant Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Guardant Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Guardant Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Potter Myrtle S over a week ago Disposition of tradable shares by Potter Myrtle S of Guardant Health subject to Rule 16b-3 | ||
Joyce Meghan V. over two weeks ago Disposition of tradable shares by Joyce Meghan V. of Guardant Health subject to Rule 16b-3 | ||
Merrill Amelia over three weeks ago Acquisition by Merrill Amelia of 158 shares of Guardant Health subject to Rule 16b-3 | ||
Michael Bell over a month ago Disposition of 1233 shares by Michael Bell of Guardant Health subject to Rule 16b-3 | ||
Michael Wiley over six months ago Sale by Michael Wiley of 2357 shares of Guardant Health | ||
AmirAli Talasaz over a year ago Purchase by AmirAli Talasaz of 27813 shares of Guardant Health | ||
Tariq Musa over a year ago Acquisition by Tariq Musa of 11992 shares of Guardant Health subject to Rule 16b-3 |
Guardant Health Predictive Daily Indicators
Guardant Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Guardant Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Guardant Health Corporate Filings
F4 | 16th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of April 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 5th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 2nd of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 1st of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 19th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 18th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Guardant Health Forecast Models
Guardant Health's time-series forecasting models are one of many Guardant Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Guardant Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Guardant Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Guardant Health. By using and applying Guardant Stock analysis, traders can create a robust methodology for identifying Guardant entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.85) | (0.89) | |
Operating Profit Margin | (1.00) | (1.05) | |
Net Loss | (0.85) | (0.89) | |
Gross Profit Margin | 0.60 | 0.43 |
Current Guardant Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Guardant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Guardant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
53.0 | Strong Buy | 18 | Odds |
Most Guardant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Guardant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Guardant Health, talking to its executives and customers, or listening to Guardant conference calls.
Guardant Stock Analysis Indicators
Guardant Health stock analysis indicators help investors evaluate how Guardant Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Guardant Health shares will generate the highest return on investment. By understating and applying Guardant Health stock analysis, traders can identify Guardant Health position entry and exit signals to maximize returns.
Begin Period Cash Flow | 141.6 M | |
Long Term Debt | 1.1 B | |
Common Stock Shares Outstanding | 112 M | |
Total Stockholder Equity | 158.7 M | |
Tax Provision | 685 K | |
Property Plant And Equipment Net | 302.7 M | |
Cash And Short Term Investments | 1.2 B | |
Cash | 1.1 B | |
Accounts Payable | 51.7 M | |
Net Debt | 220.2 M | |
50 Day M A | 19.1546 | |
Total Current Liabilities | 205.9 M | |
Other Operating Expenses | 1.1 B | |
Non Current Assets Total | 439.3 M | |
Non Currrent Assets Other | 124.2 M | |
Stock Based Compensation | 90.8 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.